ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Exploring vitamin K2 and B12 as bioactive micronutrients for dentin conditioning in regenerative endodontics procedures.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study assessed the potential of vitamins K2 and B12 as dentin surface conditioners to modulate the regenerative behavior of human periodontal ligament stem cells (hPDLSCs). hPDLSCs were isolated and characterized by flow cytometry, which confirmed the mesenchymal stem cell phenotype. Cell viability assays showed no cytotoxicity at the tested concentrations; therefore, 16 µg/mL was selected for further analysis. Both vitamins significantly enhanced cell migration, attachment to dentin disks, and mineralization potential, as demonstrated by Alizarin Red staining and alkaline phosphatase activity after 14 days of osteogenic induction. Gene expression analysis revealed that vitamin B12 primarily upregulated RUNX2, whereas vitamin K2 increased the expression of osteoprotegerin, osteocalcin, dentin sialophosphoprotein, and cementum protein 1. Furthermore, both vitamins reduced the expression of nuclear factor kappa-B and interleukin-6 and increased glutathione levels, with vitamin B12 exhibiting stronger anti-inflammatory and antioxidant effects. Despite these variations, no significant differences were observed between the two vitamins in terms of cell proliferation, mineralized nodule formation, or alkaline phosphatase activity, suggesting a comparable overall regenerative potential. These findings indicate that vitamins K2 and B12 are biocompatible and promote favorable hPDLSC responses through distinct molecular pathways. They may serve as practical, chairside-applied micronutrient conditioners in regenerative endodontic procedures, potentially improving the treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.